CHARLSIE RECORD: Open Payments
NPI 1972028249 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,813 in 95 payments from 16 companies in 2025. Trend: 2023 $1,993 · 2024 $1,797 · 2025 $1,813
Food & beverage: $1,813
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 15 | $253 |
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $224 |
| AstraZeneca Pharmaceuticals LP | 11 | $221 |
| Merck Sharp & Dohme LLC | 10 | $197 |
| Amgen Inc. | 11 | $193 |
| Novo Nordisk Inc | 8 | $147 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $145 |
| Alnylam Pharmaceuticals Inc. | 6 | $144 |
| Lilly USA, LLC | 3 | $59 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
Products named: Kerendia, VERQUVO, REPATHA, JARDIANCE, FARXIGA, VYNDAQEL, Wegovy, ELIQUIS.
Industry payments across OK — which companies pay providers there.
